The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
Cannabis
Cognition
First-Episode Psychosis (FEP)
Schizophrenia
Substance use
Journal
Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
04
03
2020
revised:
21
08
2020
accepted:
22
08
2020
pubmed:
31
8
2020
medline:
24
2
2021
entrez:
31
8
2020
Statut:
ppublish
Résumé
Cannabis use is highly prevalent among young people diagnosed with first-episode psychosis (FEP), however, its impact on cognition is still unclear. The aim of the present study was to examine the association of cannabis use with cognition in people diagnosed with FEP. We extended previous research findings by operationalising the comorbid cannabis use, considering recency of cannabis use and use of other illicit substances and including people with a broad spectrum of psychotic diagnoses. A total of 89 people diagnosed with FEP were interviewed about their history of substance use and completed a cognitive test battery assessing verbal memory, verbal fluency and attention. Sixty-one participants were lifetime cannabis users (CU; ≥three times per week for ≥four weeks; 68.5%) and 28 were cannabis non-users (CNU; 31.5%). CU were significantly more likely to be male and exhibited significantly more positive symptoms than CNU. In contrast, CNU displayed significantly more negative symptoms than CU. There were no differences between CU and CNU on neurocognitive tasks of verbal memory, verbal fluency and attention. In conclusion, there was no indication that cannabis use was associated with cognitive impairments in people diagnosed with FEP.
Identifiants
pubmed: 32862065
pii: S0165-1781(20)30441-8
doi: 10.1016/j.psychres.2020.113424
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
113424Informations de copyright
Copyright © 2020. Published by Elsevier B.V.